Blog

The powerful and impactful documentary by Kirby Dick, Amy Ziering and Amy Herdy exposes the lax approval process of medical devices in an industry where profits are prioritized over patients. Essure Problems advocates traveled to New York for the film premiere which exposes the medical device industry and the complicit FDA.

Yesterday the FDA announced it would restrict the sale and distribution of Essure to protect women and ensure that patients receive risk information. However, the welcome regulatory action goes much further.

In the last few month, Essure lawsuits have risen significantly from 10,600 to over 16,000. Women should seek counsel as their time to file a claim may be expiring soon.

Following a meeting with the Essure Problems Administrators, attorney Holly Ennis and data specialist, Madris Tomes, FDA Commissioner Scott Gottlieb writes a response which has many Essure victims seeing red.

It has been nearly a month since Essure Problems Administrators, Madris Tomes and attorney Holly Ennis met with FDA Commissioner Scott Gottlieb to discuss remedial actions concerning Essure. There has been no acknowledgment or word from the FDA following this meeting and the Essure Problems Group wants answers. and action.

Advocates from the Essure Problems Group, including administrators, attorneys and a data specialist, met with FDA Commissioner Scott Gottlieb yesterday to discuss the ongoing problems with the controversial sterilization device Essure and to persuade the FDA to suspend Essure's PMA pending the outcome of the current clinical trials set for completion in 2023.

A new French study comparing the outcomes of women undergoing the Essure Sterilization procedure versus laparoscopic sterilization has once again ignited the heated debate regarding the safety of the highly controversial Essure device.

As we ring in the new year, an insightful review of the evolution of the Essure Sterilization Device and the movement to stop it.

The FDA has recommended that Primus Pharmaceuticals. the manufacturer of Limbrel voluntarily recall the controversial drug product due to serious and potentially life-threatening side effects.

Despite repeated requests by multiple Congresswomen and Administrators from the Essure Problems Facebook Group, FDA Commissioner Scott Gottlieb, refuses to allow any women affected by the device to attend meetings with the Congresswomen to discuss the safety of the device.